On November 6, 2008, CDEX announced record ValiMed sales and a more than doubling of its hospital client base in FY08, which ended October 31. Eleven ValiMed units were sold or leased in the fourth quarter and, in addition, a backlog of orders exists. Going into FY09 with a backlog and a strong sales pipeline, CDEX projected that in the first six months of FY09 it will sell or lease over 25 new ValiMed units, continuing the trend of year-over-year growth. CDEX further announced the introduction of the next generation of ValiMed systems at the upcoming American Society of Health-System Pharmacists meeting in Orlando, Florida, in December. These new models and applications are flexible and designed to accommodate the varying requirements of CDEX customers worldwide. CDEX also anticipates that its strong U.S. sales pipeline should result in continued growth of the market share and branding of ValiMed as a standard of medication safety. CDEX further expects that its international expansion should continue in FY09 with the addition of new distributor geographies and opportunities related to co-development and marketing initiatives with key partners in Europe to customize its medication signatures offering for the ValiMed Systems. CDEX believes that it will sell more ValiMed Units in the first six months of the new fiscal year than in all of FY08.

(d) Exhibits.

Exhibit
Number          Title of Document
------          -----------------
99.1            Press Release, dated November 6, 2008